HomeBristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point dealFILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is

FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is

FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured at the headquarters in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau/File Photo

FILE PHOTO: A woman holds test tube in front of

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

August 3, 2023

For investors, green companies still hard to find with new emissions reporting rules

August 3, 2023

Pope, in Portugal to rally young Catholics, says Church needs purification

August 3, 2023

Wall Street ends down, investors step back after Fitch US rating cut

August 2, 2023

FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is

Most Read

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

For investors, green companies still hard to find with new emissions reporting rules

Pope, in Portugal to rally young Catholics, says Church needs purification

Wall Street ends down, investors step back after Fitch US rating cut

EDITOR PICKS

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

For investors, green companies still hard to find with new emissions reporting rules

Pope, in Portugal to rally young Catholics, says Church needs purification

POPULAR POSTS

Eyeing China in the Pacific, US studies explosives to make missiles fly farther

For investors, green companies still hard to find with new emissions reporting rules

Pope, in Portugal to rally young Catholics, says Church needs purification

POPULAR CATEGORY